OTC Markets OTCPK - Delayed Quote USD
HLS Therapeutics Inc. (HLTRF)
3.4400
0.0000
(0.00%)
At close: May 2 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
56,619
56,619
63,074
61,467
60,009
Cost of Revenue
8,997
8,997
7,624
4,981
3,972
Gross Profit
47,622
47,622
55,450
56,486
56,037
Operating Expense
55,308
55,308
65,799
69,983
62,321
Operating Income
-7,686
-7,686
-10,349
-13,497
-6,284
Net Non Operating Interest Income Expense
-9,764
-9,764
-8,398
-7,260
-6,912
Other Income Expense
1,868
1,868
-9,056
-2,965
1,388
Pretax Income
-15,582
-15,582
-27,803
-23,722
-11,808
Tax Provision
4,073
4,073
-272
-124
1,309
Net Income Common Stockholders
-19,655
-19,655
-27,531
-23,598
-13,117
Diluted NI Available to Com Stockholders
-19,655
-19,655
-27,531
-23,598
-13,117
Basic EPS
-0.69
-0.62
-0.85
-0.73
-0.41
Diluted EPS
-0.69
-0.62
-0.85
-0.73
-0.41
Basic Average Shares
31,914.8400
31,839.4740
32,263.2970
32,432.8510
32,184.0760
Diluted Average Shares
31,914.8400
31,839.4740
32,263.2970
32,432.8510
32,184.0760
Total Operating Income as Reported
--
--
--
--
-6,284
Total Expenses
64,305
64,305
73,423
74,964
66,293
Net Income from Continuing & Discontinued Operation
-19,655
-19,655
-27,531
-23,598
-13,117
Normalized Income
-18,368.9500
-18,368.9500
-18,563.5959
-20,648.4987
-14,137.1800
Interest Income
319
319
350
57
44
Interest Expense
10,083
10,083
8,748
7,317
6,956
Net Interest Income
-9,764
-9,764
-8,398
-7,260
-6,912
EBIT
-5,499
-5,499
-19,055
-16,405
-4,852
EBITDA
17,218
17,218
12,884
17,997
25,412
Reconciled Cost of Revenue
8,997
8,997
7,624
4,981
3,972
Reconciled Depreciation
22,717
22,717
31,939
34,402
30,264
Net Income from Continuing Operation Net Minority Interest
-19,655
-19,655
-27,531
-23,598
-13,117
Total Unusual Items Excluding Goodwill
-1,513
-1,513
-9,056
-2,965
1,388
Total Unusual Items
-1,513
-1,513
-9,056
-2,965
1,388
Normalized EBITDA
18,731
18,731
21,940
20,962
24,024
Tax Rate for Calcs
0.0002
0.0002
0
0
0.0003
Tax Effect of Unusual Items
-226.9500
-226.9500
-88.5959
-15.4987
367.8200
12/31/2021 - 1/27/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SEHCF Sweet Earth Holdings Corporation
0.5320
0.00%
BIOGY BioGaia AB (publ)
10.81
0.00%
CANQF CanaQuest Medical Corp.
0.0140
0.00%
MJ.CN Maven Brands Inc.
0.0200
0.00%
BGLAF BioGaia AB (publ)
9.58
0.00%
NMV.F Captor Capital Corp.
0.2940
-3.29%
RAMM.CN RAMM Pharma Corp.
0.0150
0.00%
XTXXF Adastra Holdings Ltd.
0.0378
0.00%
MJRX.CN Global Health Clinics Ltd.
0.0100
0.00%
CNADF CanadaBis Capital Inc.
0.0625
0.00%